Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
Protecting Clinical Trial Supply Chains from Geopolitical Risk
Read More
white-paper
Commissioner’s National Priority Voucher (CNPV) Pilot Program
Read More
post
Digital QMS & Emerging AI Tools in Pharmaceutical Quality Management
Read More
infographic
What You Should Know About the FDA’s New CNPV Pilot Program
Read More
Let's move from science to success.
Let’s Talk